BioRadar PBC
BioRadar provides a continuously operating, AI-enabled biological intelligence service aimed at early detection and characterization of emerging biological threats. Through integration of multimodal environmental, clinical, and behavioral data, BioRadar delivers real-time threat assessments and operational guidance to public sector agencies, healthcare systems, and other critical organizations. The platform is designed to address modern biological risk environments, including engineered pathogens and natural outbreaks, by establishing local biological baselines and employing advanced AI for anomaly detection.
Industries
Nr. of Employees
small (1-50)
BioRadar PBC is currently seeking investment
BioRadar PBC is seeking a pre-seed investment in the range of 1m-5m
Products
A real-time biosurveillance platform utilizing AI, metagenomics, and multimodal data to detect, assess, and deliver actionable intelligence on emerging biological threats.
A real-time biosurveillance platform utilizing AI, metagenomics, and multimodal data to detect, assess, and deliver actionable intelligence on emerging biological threats.
Services
Customized briefings—classified or unclassified—for organizations on biosurveillance risk, detection, and preparedness strategies, delivered on request.
Customized briefings—classified or unclassified—for organizations on biosurveillance risk, detection, and preparedness strategies, delivered on request.
Expertise Areas
- Biosurveillance
- AI-driven biological threat detection
- Metagenomic analysis
- Public health risk assessment
Key Technologies
- Environmental metagenomic sequencing
- AI/ML anomaly detection algorithms
- Multimodal data integration
- Real-time analytics dashboards
Key People
News & Updates
Co-founders analyze a cruise ship outbreak in The Boston Globe, highlighting detection system failures and the need for earlier threat identification.
PBS NewsHour covers the hantavirus outbreak and public health lessons, featuring BioRadar’s founders on detection gaps.
Ashish Jha's op-ed in STAT News explains risks of current biosurveillance inadequacies and the importance of AI-enabled solutions.
Ashish Jha provides expert guidance on avian influenza and public health response in a Good Morning America interview.
Nikki Romanik’s op-ed raises concerns about the closure of the U.S. Office of Pandemic Preparedness and associated preparedness gaps.
A co-authored piece argues that reducing CDC’s international programs weakens U.S. biodefense.
Co-founders analyze a cruise ship outbreak in The Boston Globe, highlighting detection system failures and the need for earlier threat identification.
PBS NewsHour covers the hantavirus outbreak and public health lessons, featuring BioRadar’s founders on detection gaps.
Ashish Jha's op-ed in STAT News explains risks of current biosurveillance inadequacies and the importance of AI-enabled solutions.
Ashish Jha provides expert guidance on avian influenza and public health response in a Good Morning America interview.
Nikki Romanik’s op-ed raises concerns about the closure of the U.S. Office of Pandemic Preparedness and associated preparedness gaps.
A co-authored piece argues that reducing CDC’s international programs weakens U.S. biodefense.